

NCT02462590 Raw comparison:

Summary:
CHIA has 11 criteria while your personal folder has 12 criteria
Total found criteria: 11/11
Total not Found: 0/11
Total Extra: 1
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Adults = 18 years of age                           │ Adults ≥ 18 years of age                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Admitted to any ICU and receiving invasive         │ Admitted to any ICU and receiving invasive         │
│ mechanical ventilation                             │ mechanical ventilation                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Anticipated ventilation of =72 hours at the time   │ Anticipated ventilation of ≥72 hours at the time   │
│ of screening as per the ICU physician              │ of screening as per the ICU physician              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Invasively mechanically ventilated >72 hours at    │ Invasively mechanically ventilated \>72 hours at   │
│ the time of screening                              │ the time of screening                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients at potential increased risk of iatrogenic │ Patients at potential increased risk of iatrogenic │
│ probiotic infection (see Section 2 6 for detailed  │ probiotic infection (see Section 2 6 for detailed  │
│ explanation) including specific immunocompromised  │ explanation) including specific immunocompromised  │
│ populations (HIV <200 CD4 cells/µL those receiving │ populations (HIV \<200 CD4 cells/μL those          │
│ chronic immunosuppressive medications (e g         │ receiving chronic immunosuppressive medications (e │
│ azathioprine cyclosporine cyclophosphamide         │ g azathioprine cyclosporine cyclophosphamide       │
│ tacrolimus methotrexate mycofenolate Anti-IL2)     │ tacrolimus methotrexate mycofenolate Anti-IL2)     │
│ previous transplantation (including stem cell) at  │ previous transplantation (including stem cell) at  │
│ any time malignancy requiring chemotherapy in the  │ any time malignancy requiring chemotherapy in the  │
│ last 3 months neutropenia [absolute neutrophil     │ last 3 months neutropenia \[absolute neutrophil    │
│ count < 500]) However patients receiving           │ count \< 500\]) However patients receiving         │
│ corticosteroids previously or presently or         │ corticosteroids previously or presently or         │
│ projected to receive corticosteroids are not       │ projected to receive corticosteroids are not       │
│ excluded                                           │ excluded                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients at risk for endovascular infection        │ Patients at risk for endovascular infection        │
│ (previously documented rheumatic heart disease     │ (previously documented rheumatic heart disease     │
│ congenital valve disease surgically repaired       │ congenital valve disease surgically repaired       │
│ congenital heart disease unrepaired cyanotic       │ congenital heart disease unrepaired cyanotic       │
│ congenital heart disease any intracardiac repair   │ congenital heart disease any intracardiac repair   │
│ with prosthetic material [mechanical or bio-       │ with prosthetic material \[mechanical or bio-      │
│ prosthetic cardiac valves] previous or current     │ prosthetic cardiac valves\] previous or current    │
│ endocarditis permanent endovascular devices (e g   │ endocarditis permanent endovascular devices (e g   │
│ endovascular grafts [e g aortic aneurysm repair    │ endovascular grafts \[e g aortic aneurysm repair   │
│ stents involving large arteries such as aorta      │ stents involving large arteries such as aorta      │
│ femorals and carotids] inferior vena cava filters  │ femorals and carotids\] inferior vena cava filters │
│ dialysis vascular grafts) tunnelled (not short-    │ dialysis vascular grafts) tunnelled (not short-    │
│ term) hemodialysis catheters pacemakers or         │ term) hemodialysis catheters pacemakers or         │
│ defibrillators Patients with temporary central     │ defibrillators Patients with temporary central     │
│ venous catheters central venous dialysis catheters │ venous catheters central venous dialysis catheters │
│ or peripherally inserted central catheters (PICCs) │ or peripherally inserted central catheters (PICCs) │
│ are not excluded and patients with coronary artery │ are not excluded and patients with coronary artery │
│ stents coronary artery bypass grafts (CABG) or     │ stents coronary artery bypass grafts (CABG) or     │
│ neurovascular coils are not excluded patients with │ neurovascular coils are not excluded patients with │
│ mitral valve prolapse or bicuspid aortic valve are │ mitral valve prolapse or bicuspid aortic valve are │
│ not excluded providing they have no other          │ not excluded providing they have no other          │
│ exclusion criteria                                 │ exclusion criteria                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with a primary diagnosis of severe acute  │ Patients with a primary diagnosis of severe acute  │
│ pancreatitis without reference to a Ranson score   │ pancreatitis without reference to a Ranson score   │
│ [Ranson 1974]) However patients with mild or       │ \[Ranson 1974\]) However patients with mild or     │
│ moderate pancreatitis are not excluded             │ moderate pancreatitis are not excluded             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with percutaneous gastric or jejunal      │ Patients with percutaneous gastric or jejunal      │
│ feeding tubes already in situ as per Health Canada │ feeding tubes already in situ as per Health Canada │
│ guidance                                           │ guidance                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Strict contraindication or inability to receive    │ Strict contraindication or inability to receive    │
│ enteral medications                                │ enteral medications                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Intent to withdraw advanced life support as per    │ Intent to withdraw advanced life support as per    │
│ the ICU physician                                  │ the ICU physician                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Previous enrolment in this or current enrolment in │ Previous enrolment in this or current enrolment in │
│ a potentially confounding tria                     │ a potentially confounding tria                     │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 18 Years │
╘═══════════════════════════════════╛